Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026)
Omeros (OMER) reported Change in Acquisitions & Divestments of $30.0 million for Q1 2026, down 23.54% on a YoY basis from $39.3 million in Q1 2025, and down 21.74% sequentially from $38.4 million in Q4 2025.
Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $30.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 23.54% year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $100.6 million (down 85.27% YoY), and the FY2025 full-year result was $109.9 million, down 89.73% from the prior year.
- Change in Acquisitions & Divestments fell to $30.0 million in Q1 2026, from $38.4 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $425.7 million in Q1 2024 to a low of $6.2 million in Q1 2022.
- A 5-year average of $150.5 million and a median of $100.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments jumped 5425.97% in 2023 and tumbled 96.84% in 2025, its largest moves.
- Tracing OMER's Change in Acquisitions & Divestments over 5 years: stood at $217.0 million in 2022, then jumped by 36.12% to $295.4 million in 2023, then plunged by 65.96% to $100.5 million in 2024, then slumped by 61.81% to $38.4 million in 2025, then retreated by 21.74% to $30.0 million in 2026.
- Business Quant data shows OMER's Change in Acquisitions & Divestments at $30.0 million in Q1 2026, $38.4 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Omeros | 810.87 Mn | 810.87 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.05 Mn |
| Mar 31, 2026 | 30.05 Mn |
| Dec 31, 2025 | 38.40 Mn |
| Dec 31, 2025 | 38.40 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 21.70 Mn |
| Jun 30, 2025 | 21.70 Mn |
| Mar 31, 2025 | 39.30 Mn |
| Mar 31, 2025 | 39.30 Mn |
| Dec 31, 2024 | 100.55 Mn |
| Dec 31, 2024 | 100.55 Mn |
| Sep 30, 2024 | 331.81 Mn |
| Sep 30, 2024 | 331.81 Mn |
| Jun 30, 2024 | 211.73 Mn |
| Jun 30, 2024 | 211.73 Mn |
| Mar 31, 2024 | 425.69 Mn |
| Mar 31, 2024 | 425.69 Mn |
| Dec 31, 2023 | 295.37 Mn |
| Dec 31, 2023 | 295.37 Mn |